The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Xilio Therapeutics Inc’s current trading price is -32.60% away from its 52-week high, while its distance from the 52-week low is 160.11%. The stock’s price range for this period has been between $0.50 and $1.93 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 105.4 million for the day, a number notably higher than the average daily volume of 0.48 million over the last three months.
Xilio Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $1.93 on 03/28/24, while the lowest price for the same period was registered at $0.50 on 02/14/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Xilio Therapeutics Inc (XLO) has experienced a quarterly rise of 31.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 59.52M and boasts a workforce of 73 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9437, with a change in price of +0.5103. Similarly, Xilio Therapeutics Inc recorded 1,442,448 in trading volume during the last 100 days, posting a change of +62.64%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for XLO stands at 0.40. Similarly, the long-term debt-to-equity ratio is also 0.35.
XLO Stock Stochastic Average
Xilio Therapeutics Inc’s raw stochastic average for the past 50 days is presently 78.09%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 78.09%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 29.47% and 14.39%, respectively.
XLO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 36.21% this year. Over the last six months, there has been a weaker performance of 55.88%. The price of XLO fallen by 18.25% during the last 30 days period. For the last 5-days stocks have improved 87.76%.
